| Symbol | AUPH |
|---|---|
| Name | AURINIA PHARMACEUTICALS INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | #140, 14315 - 118 AVENUE, EDMONTON, A0 T5L 4S6 |
| Telephone | 250-744-2487 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
New Form DEF 14A - Aurinia Pharmaceuticals Inc. <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001600620-26-000039 <b>Size:</b> 3 MB
Read moreNew Form 3 - Aurinia Pharmaceuticals Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001600620-26-000030 <b>Size:</b> 14 KB
Read moreNew Form 3 - Aurinia Pharmaceuticals Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001600620-26-000029 <b>Size:</b> 14 KB
Read moreAurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Read moreAurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Read moreNew Form SCHEDULE 13D/A - Aurinia Pharmaceuticals Inc. <b>Filed:</b> 2026-03-25 <b>AccNo:</b> 0001214659-26-003784 <b>Size:</b> 12 KB
Read more(97% Neutral) AURINIA PHARMACEUTICALS INC. (AUPH) Provides Update on best for no small part due to Peter’s stewardship
Read more